Nanollose Limited (NC6.AX)

AUD 0.02

(0.0%)

Total Assets Summary of Nanollose Limited

  • Nanollose Limited's latest annual total assets in 2024 was 241.95 Thousand AUD , down -61.79% from previous year.
  • Nanollose Limited's latest quarterly total assets in 2024 FY was 241.95 Thousand AUD , down -61.79% from previous quarter.
  • Nanollose Limited reported annual total assets of 633.23 Thousand AUD in 2023, down -66.84% from previous year.
  • Nanollose Limited reported annual total assets of 1.9 Million AUD in 2022, down -43.52% from previous year.
  • Nanollose Limited reported quarterly total assets of 923.04 Thousand AUD for 2024 Q2, up 45.77% from previous quarter.
  • Nanollose Limited reported quarterly total assets of 241.95 Thousand AUD for 2024 Q4, down -73.79% from previous quarter.

Annual Total Assets Chart of Nanollose Limited (2024 - 2015)

Historical Annual Total Assets of Nanollose Limited (2024 - 2015)

Year Total Assets Total Assets Growth
2024 241.95 Thousand AUD -61.79%
2023 633.23 Thousand AUD -66.84%
2022 1.9 Million AUD -43.52%
2021 3.38 Million AUD 230.89%
2020 1.02 Million AUD -20.02%
2019 1.27 Million AUD -60.1%
2018 3.2 Million AUD -27.4%
2017 4.41 Million AUD 42670.53%
2016 10.31 Thousand AUD -27.76%
2015 14.27 Thousand AUD 0.0%

Peer Total Assets Comparison of Nanollose Limited

Name Total Assets Total Assets Difference
EZZ Life Science Holdings Limited 25.55 Million AUD 99.053%
Anatara Lifesciences Ltd 1.67 Million AUD 85.524%
Zelira Therapeutics Limited 5.18 Million AUD 95.332%
Biome Australia Limited 8.27 Million AUD 97.077%
Patrys Limited 4.16 Million AUD 94.186%
Orthocell Limited 26.61 Million AUD 99.091%
Imugene Limited 151.39 Million AUD 99.84%
Noxopharm Limited 6.78 Million AUD 96.433%
PYC Therapeutics Limited 91.23 Million AUD 99.735%
Chimeric Therapeutics Limited 15.27 Million AUD 98.416%
Prescient Therapeutics Limited 20.39 Million AUD 98.814%
Proteomics International Laboratories Limited 10.87 Million AUD 97.775%
Cynata Therapeutics Limited 8.38 Million AUD 97.116%
CSL Limited 56.93 Billion AUD 100.0%
Arovella Therapeutics Limited 13.28 Million AUD 98.179%
Bio-Gene Technology Limited 3.15 Million AUD 92.342%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 99.895%
Starpharma Holdings Limited 36.81 Million AUD 99.343%
Memphasys Limited 12.43 Million AUD 98.054%
Invex Therapeutics Ltd 6.12 Million AUD 96.047%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD 95.549%
Amplia Therapeutics Limited 14.84 Million AUD 98.37%
Botanix Pharmaceuticals Limited 112.46 Million AUD 99.785%
Island Pharmaceuticals Limited 2.56 Million AUD 90.565%
Race Oncology Limited 20.22 Million AUD 98.804%
Nyrada Inc. 5.9 Million AUD 95.904%
Telix Pharmaceuticals Limited 398.3 Million AUD 99.939%
Dimerix Limited 32.07 Million AUD 99.246%
PharmAust Limited 11.12 Million AUD 97.825%
Immutep Limited 147.44 Million AUD 99.836%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 99.844%
Alterity Therapeutics Limited 19.22 Million AUD 98.741%
BTC Health Limited 5.14 Million AUD 95.301%
Acrux Limited 8.96 Million AUD 97.301%
Neuren Pharmaceuticals Limited 247.97 Million AUD 99.902%
Biotron Limited 493.47 Thousand AUD 50.97%
Tissue Repair Ltd 19.38 Million AUD 98.752%
AdAlta Limited 5.57 Million AUD 95.659%
Radiopharm Theranostics Limited 72.03 Million AUD 99.664%
Hexima Limited 2.26 Million AUD 89.337%
AnteoTech Limited 9.38 Million AUD 97.421%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 99.117%
Recce Pharmaceuticals Ltd 6.36 Million AUD 96.201%
Avecho Biotechnology Limited 7.31 Million AUD 96.694%
Actinogen Medical Limited 21.31 Million AUD 98.865%
Immuron Limited 15.54 Million AUD 98.444%
Argenica Therapeutics Limited 16.37 Million AUD 98.523%